Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Frank Bennett

Showing results (151-160 of 169) with videos related to

Pageof 17
Sort By:
The New England Journal of Medicine|May 7, 2019
Targeting Huntingtin Expression in Patients with Huntington's DiseaseSarah J Tabrizi, Blair R Leavitt, G Bernhard Landwehrmeyer, et al.
American Journal of Human Genetics|January 31, 2017
Neurocalcin Delta Suppression Protects against Spinal Muscular Atrophy in Humans and across Species by Restoring Impaired EndocytosisMarkus Riessland, Anna Kaczmarek, Svenja Schneider, et al.
JCI Insight|March 8, 2021
α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson's diseaseTracy A Cole, Hien Zhao, Timothy J Collier, et al.
Biorxiv : the Preprint Server for Biology|November 22, 2024
Suppression of Huntington's Disease Somatic Instability by Transcriptional Repression and Direct CAG Repeat BindingElla W Mathews, Sydney R Coffey, Annette Gärtner, et al.
Science (New York, N.Y.)|March 17, 2023
Mechanism of <i>STMN2</i> cryptic splice-polyadenylation and its correction for TDP-43 proteinopathiesMichael W Baughn, Ze'ev Melamed, Jone López-Erauskin, et al.
Nature Reviews. Drug Discovery|February 26, 2024
Opportunities and challenges for innovative and equitable healthcareDavid J Ecker, Clarice D Aiello, Joseph R Arron, et al.
Nature Communications|November 14, 2025
Suppression of Huntington's Disease Somatic Instability by Transcriptional Repression and Direct CAG Repeat BindingElla W Mathews, Sydney R Coffey, Annette Gärtner, et al.
Neuron|October 25, 2016
Protein-RNA Networks Regulated by Normal and ALS-Associated Mutant HNRNPA2B1 in the Nervous SystemFernando J Martinez, Gabriel A Pratt, Eric L Van Nostrand, et al.
Nature Neuroscience|November 23, 2023
Stathmin-2 loss leads to neurofilament-dependent axonal collapse driving motor and sensory denervationJone López-Erauskin, Mariana Bravo-Hernandez, Maximiliano Presa, et al.
The Lancet. Neurology|February 21, 2023
Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trialCharles A Thornton, Richard Thomas Moxley, Katy Eichinger, et al.
Pageof 17

Showing results (151-160 of 169) with videos related to

Sort By:
Pageof 17
The New England Journal of Medicine|May 7, 2019
Targeting Huntingtin Expression in Patients with Huntington's DiseaseSarah J Tabrizi, Blair R Leavitt, G Bernhard Landwehrmeyer, et al.
American Journal of Human Genetics|January 31, 2017
Neurocalcin Delta Suppression Protects against Spinal Muscular Atrophy in Humans and across Species by Restoring Impaired EndocytosisMarkus Riessland, Anna Kaczmarek, Svenja Schneider, et al.
JCI Insight|March 8, 2021
α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson's diseaseTracy A Cole, Hien Zhao, Timothy J Collier, et al.
Biorxiv : the Preprint Server for Biology|November 22, 2024
Suppression of Huntington's Disease Somatic Instability by Transcriptional Repression and Direct CAG Repeat BindingElla W Mathews, Sydney R Coffey, Annette Gärtner, et al.
Science (New York, N.Y.)|March 17, 2023
Mechanism of <i>STMN2</i> cryptic splice-polyadenylation and its correction for TDP-43 proteinopathiesMichael W Baughn, Ze'ev Melamed, Jone López-Erauskin, et al.
Nature Reviews. Drug Discovery|February 26, 2024
Opportunities and challenges for innovative and equitable healthcareDavid J Ecker, Clarice D Aiello, Joseph R Arron, et al.
Nature Communications|November 14, 2025
Suppression of Huntington's Disease Somatic Instability by Transcriptional Repression and Direct CAG Repeat BindingElla W Mathews, Sydney R Coffey, Annette Gärtner, et al.
Neuron|October 25, 2016
Protein-RNA Networks Regulated by Normal and ALS-Associated Mutant HNRNPA2B1 in the Nervous SystemFernando J Martinez, Gabriel A Pratt, Eric L Van Nostrand, et al.
Nature Neuroscience|November 23, 2023
Stathmin-2 loss leads to neurofilament-dependent axonal collapse driving motor and sensory denervationJone López-Erauskin, Mariana Bravo-Hernandez, Maximiliano Presa, et al.
The Lancet. Neurology|February 21, 2023
Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trialCharles A Thornton, Richard Thomas Moxley, Katy Eichinger, et al.
Pageof 17